fluconazol new triazol antifung agent fluconazol fluorine-substitut bis-triazol antifung agent mechan action azol interrupt convers lanosterol cytochrom subsequ disrupt fungal membran activ aspergillu blastomyc dermatitidi candida coccidioid immiti cryptococcu histoplasma capsulatum paracoccidioid brasiliensi sever anim model fluconazol mean peak serum concentr human volunt mg oral mumols/l protein bind low percent cerebrospin fluid ratio serum half-lif long hour elimin renal clearanc unchang drug clinic trial report support use fluconazol treatment candidiasi oropharyng esophag infect immunocompromis host fluconazol initi suppress therapi cryptococc mening role manag system fungal infect result compar trial avail fluconazol effect steroidogenesi ketoconazol antipyrin clearanc low dose mg fluconazol drug interact use dose agent cyclosporin phenytoin oral hypoglycem warfarin rifampin metabol clearanc fluconazol fluconazol avail oral parenter formul once-daili dose mg dosag reduct patient impair renal function 